Resumen
Una analgesia inadecuada en cirugía torácica facilita las complicaciones respiratorias potencialmente graves y se asocia al síndrome de dolor crónico post-toracotomía. El catéter epidural y el catéter paravertebral son los tratamientos que resultan más efectivos, dentro de una estrategia multimodal. El parche de lidocaína 5 % está indicado para el dolor en la neuropatía post-herpética. Existe literatura sobre su utilidad en otros modelos de dolor. Presentamos tres pacientes con dolor postquirúrgico en cirugía de tórax, a pesar del tratamiento convencional, y su buena respuesta analgésica tras la aplicación de parche de lidocaína 5 %.Referencias
1. Gerner P. Post-thoracotomy pain management problems. Anesthesiol Clin 2008;26:355-67.
2. Kalso E, Mennander S, Tasmuth T, Nilsson E. Chronic post-sternotomy pain. Acta Anaesthesiol Scand 2001;45:935-9.
3. Schug S, Pogatzki-Zahn E. Chronic pain after surgery or injury. International association for the study of pain, pain clinical updates 2011;XIX(1):1-5.
4. Raveglia F, Rizzi A, Leporati A, Di Mauro P, Cioffi U, Baisi A. Analgesia in patients undergoing thoracotomy: Epidural versus paravertebral technique. A randomized, double-blind, prospective study. J Thorac Cardiovasc Surg 2013;147:469-73.
5. De Leon-Casasola OA. Multimodal approaches to the management of neuropathic pain: The role of topical analgesia. J Pain Symptom Manage 2007;33:356-64.
6. Krumova E, Zeller M, Westermann A, Maier C. Lidocaine patch (5 %) produces a selective, but incomplete block of Aδ and C fibers. Pain 2012;153:273-80.
7. Marchetti-Filho MA, Leão LE, Costa-Junior Ada S. The role of intercostal nerve preservation in acute pain control after thoracotomy. J Bras Pneumol 2014;40(2):164-70.
8. Gammaitoni AR, Alvarez NA, Galer BS. Pharmacokinetics and safety of continously applied lidocaine patches 5 %. Am J Health Syst Pharm 2002;59:2215-20.
9. Lidocaïna al 5 % en pegats per al dolor neuropàtic en pacients amb càncer. Informe per a la comissió de Farmacia i Terapèutica de l`Institut Català d´Oncologia; 11-10-2011.
10. Meier T, Wasner G, Faust M, Kuntzer T, Ochsner F, Hueppe M, et al. Efficacy of lidocaine patch 5 % in the treatment of focal peripherals neuropathic pain syndromes: A randomized, double-blind, placebo-controlled study. Pain 2003;106:151-8.
11. Correa-Illanes G, Roa R, Piñeros JL, Calderón W. Use of 5 % lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves. Local Reg Anesth 2012;5:47-53.
12. Vidal MA, Calderón E, Torres LM. Parche de lidocaína al 5 % para el tratamiento del SDRC de extremidad superior por bloqueo transcutáneo del plexo braquial. Caso Clínico. Rev Soc Esp Dolor 2007;14:351-4.
13. Fleming JA, O’Connor BD. Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre. Pain Res Manag 2009;14:381-8.
14. Habib AS, Polascik TJ, Weizer AZ, White WD, Moul JW, ElGasim MA, et al. Lidocaine patch for postoperative analgesia after radical retropubic prostatectomy. Anesth Analg 2009;108:1950-3.
15. Saber AA, Elgamal MH, Rao AJ, Itawi EA, Martinez RL. Early experience with lidocaine patch for postoperative pain control after laparoscopic ventral hernia repair. Int J Surg 2009;7:36-8.
16. E Lockhart. Topical sterile lidocaine patch to reduce postoperative pain and decrease need for oral analgesics after inguinal herniorrhaphy. J Pain 2006;7(4suppl):S59.
17. Cheville AL, Sloan JA, Northfelt DW, Jillella AP, Wong GY, Bearden Iii JD. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: A phase III double-blind crossover study (N01CB). Support Care Cancer 2009;17:451-60.
18. Kim KH. Use of lidocaine patch for percutaneous endoscopic lumbar discectomy. Korean J Pain 2011;24:74-80.
19. Garzón C, Casals M, Calsina A, López E, Porta J. Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results. Support Care Cancer 2013;21:3153-8.
20. Bai Y, Miller T, Tan M, Law LS, Gan TJ. Lidocaine Patch for Acute Pain Management: A meta-analysis of prospective controlled trials. Curr Med Res Opin 2014;7:1-18.
